Clinical Trial

Cognitive Rehabilitation in Post-stroke Cognitive Impairment

Study acronym: CIPS-TER
Completed
View on ClinicalTrials.gov →
Summary
The goal of this 2-year, prospective, single-blind randomized clinical trial is to investigate: the efficacy in reducing the risk of cognitive impairment 6 months after stroke; the generalizability of cognitive reinforcement to real life, such as activities of daily living and quality of life; and the impact on cognitive performance. In the treatment group, feasibility, adherence, and satisfaction with the cognitive telerehabilitation program will also be evaluated. Participants will be adult patients with a diagnosis of ischemic or hemorrhagic stroke, within 5-21 days after onset. The main outcomes to be evaluated are: * diagnosis of cognitive impairment (primary outcome); * activities of daily living, quality of life, changes in frailty status, and cognitive efficiency (secondary outcomes). There will be two groups: a treatment group and a control group. Participants in the treatment group will undergo a cognitive telerehabilitation program of 40 hours over 8 weeks, while participants in the control group will be instructed to follow their standard care.
Protocol Amendment History 2 changes
critical Trial completed 2026-04-30
notable Enrollment reduced: 100 -> 86 participants 2026-04-30
Trial Details
NCT Number NCT07251517
Lead Sponsor University of Florence
Collaborators: University of Milan, University of Pavia
Conditions Cognitive Impairment, Stroke Acute
Enrollment 86 participants
Start Date 2024-04-22
Primary Completion 2026-03-20 (estimated)
Study Completion 2026-03-20 (estimated)
Updated on ClinicalTrials.gov 2026-04-29